These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24728827)

  • 1. Treatment with low-temperature atmospheric pressure plasma enhances cutaneous delivery of epidermal growth factor by regulating E-cadherin-mediated cell junctions.
    Choi JH; Nam SH; Song YS; Lee HW; Lee HJ; Song K; Hong JW; Kim GC
    Arch Dermatol Res; 2014 Sep; 306(7):635-43. PubMed ID: 24728827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface molecules on HaCaT keratinocytes after interaction with non-thermal atmospheric pressure plasma.
    Haertel B; Hähnel M; Blackert S; Wende K; von Woedtke T; Lindequist U
    Cell Biol Int; 2012; 36(12):1217-22. PubMed ID: 22973947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential down-regulation of E-cadherin with squamous cell carcinoma progression: loss of E-cadherin via a prostaglandin E2-EP2 dependent posttranslational mechanism.
    Brouxhon S; Kyrkanides S; O'Banion MK; Johnson R; Pearce DA; Centola GM; Miller JN; McGrath KH; Erdle B; Scott G; Schneider S; VanBuskirk J; Pentland AP
    Cancer Res; 2007 Aug; 67(16):7654-64. PubMed ID: 17699770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphiregulin causes functional downregulation of adherens junctions in psoriasis.
    Chung E; Cook PW; Parkos CA; Park YK; Pittelkow MR; Coffey RJ
    J Invest Dermatol; 2005 Jun; 124(6):1134-40. PubMed ID: 15955087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-thermal atmospheric-pressure plasma can influence cell adhesion molecules on HaCaT-keratinocytes.
    Haertel B; Wende K; von Woedtke T; Weltmann KD; Lindequist U
    Exp Dermatol; 2011 Mar; 20(3):282-4. PubMed ID: 21054557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of urban particulate pollution on skin barrier function and the subsequent drug absorption.
    Pan TL; Wang PW; Aljuffali IA; Huang CT; Lee CW; Fang JY
    J Dermatol Sci; 2015 Apr; 78(1):51-60. PubMed ID: 25680853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E-cadherin is essential for in vivo epidermal barrier function by regulating tight junctions.
    Tunggal JA; Helfrich I; Schmitz A; Schwarz H; Günzel D; Fromm M; Kemler R; Krieg T; Niessen CM
    EMBO J; 2005 Mar; 24(6):1146-56. PubMed ID: 15775979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of E- and P-cadherin in the human skin.
    Furukawa F; Fujii K; Horiguchi Y; Matsuyoshi N; Fujita M; Toda K; Imamura S; Wakita H; Shirahama S; Takigawa M
    Microsc Res Tech; 1997 Aug; 38(4):343-52. PubMed ID: 9297684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orally administered glucosylceramide improves the skin barrier function by upregulating genes associated with the tight junction and cornified envelope formation.
    Ideta R; Sakuta T; Nakano Y; Uchiyama T
    Biosci Biotechnol Biochem; 2011; 75(8):1516-23. PubMed ID: 21821935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor is involved in enterocyte anoikis through the dismantling of E-cadherin-mediated junctions.
    Lugo-Martínez VH; Petit CS; Fouquet S; Le Beyec J; Chambaz J; Pinçon-Raymond M; Cardot P; Thenet S
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G235-44. PubMed ID: 19056766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo microdialysis for the investigation of drug levels in the dermis and the effect of barrier perturbation on cutaneous drug penetration. Studies in hairless rats and human subjects.
    Benfeldt E
    Acta Derm Venereol Suppl (Stockh); 1999; 206():1-59. PubMed ID: 10605601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E-cadherin modulates Wnt-dependent transcription in colorectal cancer cells but does not alter Wnt-independent gene expression in fibroblasts.
    Kuphal F; Behrens J
    Exp Cell Res; 2006 Feb; 312(4):457-67. PubMed ID: 16368435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cadherin enhances cell-matrix adhesiveness by regulating beta1 integrin trafficking in cutaneous squamous carcinoma cells.
    Mukoyama Y; Utani A; Matsui S; Zhou S; Miyachi Y; Matsuyoshi N
    Genes Cells; 2007 Jun; 12(6):787-96. PubMed ID: 17573778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel method to improve transdermal drug delivery by atmospheric microplasma irradiation.
    Shimizu K; Hayashida K; Blajan M
    Biointerphases; 2015 Jun; 10(2):029517. PubMed ID: 25947391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of permeation enhancers on transdermal delivery of fluoxetine: in vitro and in vivo evaluation.
    Jung E; Kang YP; Yoon IS; Kim JS; Kwon SW; Chung SJ; Shim CK; Kim DD
    Int J Pharm; 2013 Nov; 456(2):362-9. PubMed ID: 24012861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand activation of overexpressed epidermal growth factor receptor results in colony dissociation and disturbed E-cadherin function in HSC-1 human cutaneous squamous carcinoma cells.
    Fujii K; Furukawa F; Matsuyoshi N
    Exp Cell Res; 1996 Feb; 223(1):50-62. PubMed ID: 8635495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of hepatic stimulator substance during the early phase of liver regeneration inhibits E-cadherin expression in mice.
    Zhang H; Dong LY; Sun G; An W
    Int J Biochem Cell Biol; 2014 Feb; 47():38-46. PubMed ID: 24309469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of tight junctions in skin barrier function and dermal absorption.
    Bäsler K; Bergmann S; Heisig M; Naegel A; Zorn-Kruppa M; Brandner JM
    J Control Release; 2016 Nov; 242():105-118. PubMed ID: 27521894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced expression of epidermal growth factor receptor, E-cadherin, and occludin in the skin of flaky tail mice is due to filaggrin and loricrin deficiencies.
    Nakai K; Yoneda K; Hosokawa Y; Moriue T; Presland RB; Fallon PG; Kabashima K; Kosaka H; Kubota Y
    Am J Pathol; 2012 Sep; 181(3):969-77. PubMed ID: 22796440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural products as potential drug permeation enhancer in transdermal drug delivery system.
    Patil UK; Saraogi R
    Arch Dermatol Res; 2014 Jul; 306(5):419-26. PubMed ID: 24481830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.